Edarbi is the brand name for the drug azilsartan medoxomil, a medication used to treat high blood pressure [1]. It belongs to a class of drugs called angiotensin II receptor blockers (ARBs) [1][2].
How does Edarbi work to lower blood pressure?
Edarbi works by blocking the action of angiotensin II, a substance in the body that narrows blood vessels [1][3]. By preventing this narrowing, Edarbi helps to relax blood vessels, which in turn lowers blood pressure [1].
When did Edarbi become available?
Edarbi was approved by the U.S. Food and Drug Administration (FDA) in February 2011 [4].
What is the difference between Edarbi and Edarbyclor?
Edarbyclor is a combination medication that contains both azilsartan medoxomil (Edarbi) and chlorthalidone, a diuretic [5]. Edarbi alone is used for blood pressure management, while Edarbyclor combines the effects of an ARB with a diuretic to achieve blood pressure reduction [5].
When does the patent for Edarbi expire?
The patent exclusivity for Edarbi is a key factor in its market availability and the potential for generic competition. Information on specific patent expiry dates can be found through resources like DrugPatentWatch.com [6]. The exact expiration dates can be complex due to various patent types and potential legal challenges [6].
Who manufactures Edarbi?
Edarbi is manufactured by Takeda Pharmaceuticals [1].
What are the potential side effects of taking Edarbi?
Common side effects of Edarbi can include dizziness, fatigue, and diarrhea [1]. More serious, though less common, side effects may include kidney problems or severe allergic reactions [1]. Patients should consult with their healthcare provider for a complete list of potential side effects and to discuss any concerns [1].
Can kidney patients take Edarbi?
Edarbi may need to be used with caution or may not be suitable for all individuals with kidney problems, particularly those on dialysis [1][7]. Patients with pre-existing kidney conditions should discuss their treatment plan with their doctor [1][7].
What happens if someone misses a dose of Edarbi?
If a dose of Edarbi is missed, it should be taken as soon as remembered, unless it is close to the time for the next scheduled dose [1]. In that case, the missed dose should be skipped, and the regular dosing schedule should be resumed [1]. It is important not to double the dose [1].
What are the risks associated with taking ARBs like Edarbi during pregnancy?
ARBs, including Edarbi, can cause harm or death to an unborn baby if taken during pregnancy [1]. Women who are pregnant or plan to become pregnant should consult their doctor immediately about alternative treatments [1].
What are the alternatives to Edarbi for high blood pressure?
Besides Edarbi, there are several other classes of medications used to treat high blood pressure, including other ARBs, ACE inhibitors, calcium channel blockers, beta-blockers, and diuretics [8]. The best alternative depends on individual patient factors, medical history, and response to treatment [8].
*
**Sources:
[1] https://www.drugpatentwatch.com/edarbi
[2] https://www.drugpatentwatch.com/blog/what-is-edarbi
[3] https://www.drugpatentwatch.com/blog/how-does-edarbi-work
[4] https://www.drugpatentwatch.com/blog/when-was-edarbi-approved
[5] https://www.drugpatentwatch.com/blog/what-is-edarbyclor
[6] https://www.drugpatentwatch.com/blog/edarbi-patent-expiry
[7] https://www.drugpatentwatch.com/blog/edarbi-kidney-patients
[8] https://www.drugpatentwatch.com/blog/alternatives-to-edarbi